Related Experiment Videos

Cellular effects induced by the antitumor agent azinomycin B

Gilbert T Kelly1, Chaomin Liu, Roger Smith

  • 1Department of Chemistry, Texas A&M University, College Station, Texas 77843, USA.

Chemistry & Biology
|May 25, 2006
PubMed

Insights

Azinomycin B causes DNA damage in vivo, leading to a robust DNA damage response and cell cycle changes in yeast. This study confirms its role as a covalent DNA modifying agent.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • Antitumor agent azinomycin B is proposed to work by forming DNA interstrand crosslinks.
  • Previous studies focused on in vitro mechanisms of action.

Purpose of the Study:

  • To investigate the in vivo biological effects of azinomycin B.
  • To confirm its DNA-damaging mechanism in a living organism.

Main Methods:

  • Fluorescence imaging to track azinomycin B localization in yeast.
  • Oligonucleotide microarrays to analyze transcriptome-wide effects.
  • Reverse transcription-polymerase chain reaction (RT-PCR) for gene expression validation.
  • Flow cytometry to assess cell cycle progression.

Main Results:

  • Azinomycin B localized to the nuclear region of yeast cells.
  • Significant DNA damage response observed across the yeast transcriptome.
  • RT-PCR confirmed drug-induced gene expression changes.
  • Flow cytometry revealed an S phase shift, indicating transcriptional effects.

Conclusions:

  • Azinomycin B elicits biological effects in vivo, consistent with its proposed mechanism.
  • The drug acts as a covalent DNA modifying agent, inducing a DNA damage response.
  • Transcriptional effects and cell cycle alterations are key consequences of azinomycin B treatment in vivo.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...